cbd pharma stocks

Cbd pharma stocks

Innovative Industrial Properties currently owns properties that are leased to tenants in 18 states. The company is increasing its customer base not only in the states where it already operates but also in additional states that legalize medical or recreational cannabis.

Description

Data source: Yahoo! Finance. Data current as of July 26, 2021.

Canopy Growth isn’t consistently profitable because it’s focused on growth. The company has a strong cash position as a result of a $4 billion investment from alcohol giant Constellation Brands (NYSE:STZ) . Its ties to Constellation, along with the cash from the deal, give Canopy a big advantage in the medical cannabis industry.

5. Innovative Industrial Properties

Canopy Growth serves the Canadian medical and recreational marijuana markets and distributes medical cannabis to international markets, including Germany. The company has strong global distribution channels with subsidiaries, joint ventures, and strategic partners that market its products around the world.

Trulieve Cannabis (OTC:TCNNF)

Trulieve is acquiring Harvest Health & Recreation (OTC:HRVSF) . After the deal closes, Trulieve will rank as the most profitable U.S. multistate cannabis operator. It will also be the largest U.S. cannabis company based on its combined retail and cultivation footprint.

1. Canopy Growth

Epidiolex, which generated sales of more than $510 million in 2020, is significantly boosting Jazz’s revenue. Its sales growth should continue with the European Commission’s approval in April 2021 of the drug (sold as Epidyolex in Europe) to treat seizures associated with tuberous sclerosis complex.

Jazz Pharmaceuticals (NASDAQ:JAZZ)

These are the marijuana stocks on the Nasdaq that had the highest total return over the past 12 months.

Some of the Nasdaq-listed marijuana companies include Tilray Inc. (TLRY) and OrganiGram Holdings Inc. (OGI). Many of these companies have managed to maintain fast revenue growth in spite of the COVID-19 pandemic.

Here are the top three marijuana stocks on the Nasdaq with the best value, fastest growth, and most momentum.

These are the marijuana stocks trading on the Nasdaq exchange with the lowest 12-month trailing price-to-sales (P/S) ratio. For companies in the early stages of development or industries suffering from major shocks, this can be substituted as a rough measure of a business’s value. A business with higher sales could eventually produce more profit when it achieves (or returns to) profitability. The P/S ratio shows how much you’re paying for the stock for each dollar of sales generated.

Fastest Growing Marijuana Stocks on the Nasdaq

Marijuana stocks, as represented by the ETFMG Alternative Harvest ETF (MJ), an exchange-traded fund, have significantly underperformed the broader market. MJ has provided a total return of -21.7% over the past 12 months, well below the benchmark Russell 1000 Index’s total return of 26.5%. These performance figures and all statistics in the tables below are as of Dec. 31, 2021.

The marijuana industry consists of companies directly related to the research, development, and distribution of cannabis products, as well as companies that indirectly support these operations. Traditional stock market indices such as the Nasdaq continue to include more companies from the marijuana industry, as a growing number of regions around the world legalize marijuana. The number of U.S. states that permit marijuana use in some form increased to 36 after voters in several states approved marijuana legalization initiatives on their ballots in the 2020 U.S. presidential election.

These are the top marijuana stocks on the Nasdaq as ranked by a growth model that scores companies based on a 50/50 weighting of their most recent quarterly year-over-year (YOY) percentage revenue growth and most recent quarterly YOY earnings-per-share (EPS) growth. Both sales and earnings are critical factors in the success of a company. Therefore, ranking companies by only one growth metric makes a ranking susceptible to the accounting anomalies of that quarter (such as changes in tax law or restructuring costs) that may make one figure or the other unrepresentative of the business in general. Companies with quarterly EPS or revenue growth of more than 2,500% were excluded as outliers.

GRWG, HYFM, and OGI are top for value, growth, and momentum, respectively

The comments, opinions, and analyses expressed herein are for informational purposes only and should not be considered individual investment advice or recommendations to invest in any security or adopt any investment strategy. Though we believe the information provided herein is reliable, we do not warrant its accuracy or completeness. The views and strategies described in our content may not be suitable for all investors. Because market and economic conditions are subject to rapid change, all comments, opinions, and analyses contained within our content are rendered as of the date of the posting and may change without notice. The material is not intended as a complete analysis of every material fact regarding any country, region, market, industry, investment, or strategy.